Our articles keep health professionals up-to-date with the happenings throughout the industry.
Scroll

Clinical Articles

HPS Pharmacies prides itself on providing innovative and informative support to assist in the diverse range of issues health professionals face on a day-to-day basis, and to facilitate the distribution of this information for a variety of sectors within the healthcare industry.

HPS’ clinical articles are written by HPS Pharmacies’ experienced and knowledgeable staff and are peer-reviewed by specialist leaders in their field to ensure the accuracy of the information provided. The resourceful and diverse range of articles play an integral role in keeping all health professionals up-to-date with the happenings throughout the industry on a regular basis.

Sepsis

Sepsis is a medical emergency which, if left untreated, can progress to septic shock, multi-organ failure and death. Pathogens responsible for sepsis can be bacterial, viral or fungal. Any person who acquires an infection…

Read more

Patient Self-Management

Self-management is an important aspect of chronic disease management. This approach requires patients to actively participate in their recovery in order to encourage survival, well-being and overall health and reduce the negative impacts of…

Read more

The Role of the Pharmacist in Survivorship Care

Supportive care in cancer is a collective term used to indicate services that may be needed by cancer patients and their close networks. It consists of self-help and support in the realms of psychology…

Read more

Recurrent Urinary Tract Infections in Women

Urinary tract infections (UTIs) are one of the most frequently occurring bacterial infections in women, and at least 50-60% of women will develop a UTI in their lifetime. The most common organism causing UTIs…

Read more

Enerzair® Breezhaler®

Enerzair® Breezhaler® is a triple therapy fixed dose combination inhaler containing an inhaled corticosteroid (ICS), an ultra-long-acting beta-agonist (LABA), and a long-acting muscarinic antagonist (LAMA), namely mometasone furoate, indacaterol and glycopyrronium. It is indicated…

Read more

Tirzepatide: a New Treatment for Type 2 Diabetes and Weight Loss

Tirzepatide is a new drug for the treatment of type 2 diabetes mellitus (T2DM). While it is not yet available in Australia, it has recently gained Therapeutic Goods Administration (TGA) approval for adults with…

Read more
Load More